Breathe Well Live Well
|
Asthma Therapeutics in Asia-Pacific Markets to 2021 – High Prevalence and Launch of Late-Stage Biologics will Drive …
PR Newswire (press release) Asthma is a common chronic inflammatory disease of the airways, characterized by recurrent attacks of breathlessness and wheezing, which vary in frequency and severity from patient to patient. The exact causes of asthma are currently unknown, and may … |
View full post on asthma – Google News
|
Asthma Therapeutics in Asia-Pacific Markets to 2021 – Launch of Late-Stage Biologics will Drive the Market in Spite …
Business Wire (press release) Over the 2015-2021 forecast period, the asthma therapeutics market in the Asia-Pacific region is expected to increase in value at a Compound Annual Growth Rate (CAGR) of 7.2%, from $3.5 billion to over $5.6 billion. Analysis of clinical trials since … |
View full post on asthma – Google News
BLR Eagle |
Biologics promise a new way to treat Asthma
BLR Eagle Picture this: You are suffering from Asthma, and you are trying every possible treatment available to treat your Asthma which is becoming severe day by day. But still it seems like nothing is working for you. And then a be therapy comes out of the blue … |
View full post on asthma – Google News
|
Biologics for asthma: Attacking the source of the disease, not the symptoms
Science Codex SAN ANTONIO, TX (November 5, 2015) – Imagine you suffer from severe asthma, and you've tried every treatment available, but nothing has worked. You still can't breathe. Then a new therapy comes along that attacks the source of the asthma, as opposed to … Kids with asthma can avoid the ER by avoiding the ER Breast is Best, but Might Not Protect from Allergies |
View full post on asthma – Google News
|
Asthma Therapeutics Market 2019 – Breakthrough Biologics to Enhance …
Medgadget.com (blog) Market Research Store, a leading business intelligence provider, has released its latest research report “Asthma Market to 2019”. The asthma market is forecast to grow marginally over the forecast period across the leading eight developed nations, from … |
View full post on asthma – Google News
|
Asthma market to reach $23.1 billion due to targeted biologics
Drug Store News LONDON — The asthma treatment market value will grow from approximately $15.9 billion in 2013 across eight major countries (the United States, United Kingdom, France, Germany, Spain, Italy, Japan and Australia) to $23.1 billion by 2023, according to … |
View full post on asthma – Google News
The Pharma Letter |
Global asthma market to hit $18 billion by 2021 boosted by biologics
The Pharma Letter Natasha Spiller, an analyst at Datamonitor Healthcare said: “Severe asthma remains a significant cause of mortality and morbidity and a portion of patients remain inadequately treated, despite the use of inhaled corticosteroids and long-acting beta 2 … |
View full post on asthma – Google News
|
Physicians anticipate more biologics, once-daily treatments for asthma
Healio Physicians anticipate utilizing additional once-daily and novel biologic agents that are expected to be launched in the US by 2018 to treat patients with asthma, according to survey results from Decision Resources Group. Novel biologics that target … |
View full post on asthma – Google News
|
Asthma Therapeutics Market to 2019 – Breakthrough Biologics to Enhance …
Sacramento Bee GBI Research, a leading business intelligence provider, has released its latest research report, "Asthma Therapeutics Market to 2019 – Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth". The asthma market is forecast … |
View full post on asthma – Google News
|
Asthma Therapeutics Market to 2019 – Breakthrough Biologics to Enhance …
PR Newswire (press release) GBI Research, a leading business intelligence provider, has released its latest research report, "Asthma Therapeutics Market to 2019 – Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth". The asthma market is forecast … |
View full post on asthma – Google News